Abstract

Regulatory immunity that provides resistance to relapse emerges during resolution of experimental autoimmune uveitis (EAU). This post-EAU regulatory immunity requires a melanocortin 5 receptor (MC5r)-dependent suppressor antigen presenting cell (APC), as shown using a MC5r single knock-out mouse. The MC5r-dependent APC activates an adenosine 2A receptor (A2Ar)-dependent regulatory Treg cell, as shown using an A2Ar single knock-out mouse. Unexpectedly, when MC5r-/- post-EAU APC were used to activate A2Ar-/- post-EAU T cells the combination of cells significantly suppressed EAU, when transferred to EAU mice. In contrast, transfer of the reciprocal activation scheme did not suppress EAU. In order to explain this finding, MC5r-/-A2Ar-/- double knock-out (DKO) mice were bred. Naïve DKO mice had no differences in the APC populations, or inflammatory T cell subsets, but did have significantly more Treg cells. When we examined the number of CD4 and CD8 T cell subsets, we found significantly fewer CD8 T cells in the DKO mice compared to WT and both single knock-out mice. DKO mice also had significantly reduced EAU severity and accelerated resolution. In order to determine if the CD8 T cell deficiency contributed to the resistance to EAU in the DKO mice, we transferred naïve CD8 T cells from WT mice, that were immunized for EAU. Susceptibility to EAU was restored in DKO mice that received a CD8 T cell transfer. While the mechanism that contributed to the CD8 T cell deficiency in the DKO mice remains to be determined, these observations indicate an importance of CD8 T cells in the initiation of EAU. The involvement of CD4 and CD8 T cells suggests that both class I and class II antigen presentation can trigger an autoimmune response, suggesting a much wider range of antigens may trigger autoimmune disease.

Highlights

  • Ocular inflammation, uveitis, can cause permanent damage to the light-gathering structures of the eye, resulting in permanent blindness

  • Our previous work showed that expression of the melanocortin 5 receptor (MC5r) on the postEAU antigen presenting cell (APC) is required for activation of postEAU regulatory T cells that express the adenosine 2A receptor (A2Ar)

  • When the reciprocal activation scheme was used, we found that post-Experimental autoimmune uveitis (EAU) A2Ar-/APC used to activated post-EAU MC5r-/- T cells were unable to suppress disease in recipient mice (Figure 1B)

Read more

Summary

Introduction

Uveitis, can cause permanent damage to the light-gathering structures of the eye, resulting in permanent blindness. Autoimmune uveitis patients experience relapsing and remitting inflammation, with 33% of anterior uveitis cases becoming chronic [5]. A better understanding of the immunobiology that contributes to relapsing and remitting intraocular inflammation has the potential to develop novel more effective treatments for autoimmune uveitis. In C57BL/ 6J mice, resolution of EAU occurs at 75-90 days following immunization for EAU without further relapse [7,8,9], and at this point (post-EAU) regulatory immunity is found in the spleen [10]. A critical component of post-EAU regulatory immunity is expression of the adenosine 2A receptor (A2Ar) for activation and differentiation of Treg cells, and expression of the melanocortin 5 receptor (MC5r) on the postEAU suppressor antigen presenting cell (APC) [11, 12]. A better understanding of the melanocortin-adenosinergic pathway is needed

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call